Porton Pharma Solutions Ltd
SZSE:300363
Wall Street
Price Targets
Price Targets Summary
Porton Pharma Solutions Ltd
According to Wall Street analysts, the average 1-year price target for Porton Pharma Solutions Ltd is 27.18 CNY with a low forecast of 20.5 CNY and a high forecast of 34.65 CNY.
Operating Income
Forecast
Operating Income Estimate
Porton Pharma Solutions Ltd
For the last 8 years the compound annual growth rate for Porton Pharma Solutions Ltd's operating income is 40%. The projected CAGR for the next 4 years is -41%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Porton Pharma Solutions Ltd's stock price target?
Price Target
27.18
CNY
According to Wall Street analysts, the average 1-year price target for Porton Pharma Solutions Ltd is 27.18 CNY with a low forecast of 20.5 CNY and a high forecast of 34.65 CNY.
What is Porton Pharma Solutions Ltd's Revenue forecast?
Projected CAGR
-11%
For the last 8 years the compound annual growth rate for Porton Pharma Solutions Ltd's revenue is 28%. The projected CAGR for the next 4 years is -11%.
What is Porton Pharma Solutions Ltd's Operating Income forecast?
Projected CAGR
-41%
For the last 8 years the compound annual growth rate for Porton Pharma Solutions Ltd's operating income is 40%. The projected CAGR for the next 4 years is -41%.
What is Porton Pharma Solutions Ltd's Net Income forecast?
Projected CAGR
-27%
For the last 8 years the compound annual growth rate for Porton Pharma Solutions Ltd's net income is 41%. The projected CAGR for the next 3 years is -27%.